(12-348) Cefdinir versus cefpodoxime for the treatment of f cefazolin-resistant, ceftriaxone-susceptible Enterobacterales infections

Wednesday, December 10, 2025

2:00 PM - 3:00 PM

Location: Bayside A, Level 1

Residency Program: St. Luke’s University Hospital
Residency Program Type: PGY2 (Critical Care Pharmacy)
Residency Program Location: Pennsylvania

Co-Author(s): Alex Matika, Lauren Allen, Helen Sutow

Primary Author(s)

Amanda Kearns, PharmD

Resident
St. Luke's University Health Network